Chemical Protectors against the Toxic Effects of Paracetamol (Acetaminophen) and Its Meta Analogue: Preventing Protein Arylation-Reference-Cited by-同舟云学术

Chemical Protectors against the Toxic Effects of Paracetamol (Acetaminophen) and Its Meta Analogue: Preventing Protein Arylation

Published:2018-12-27 Issue:12 Volume:3 Page:18582-18591
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Castañeda-Arriaga Romina¹,Pérez-González Adriana²,Galano Annia¹^ORCID

Affiliation:

1. Departamento de Química, Universidad Autónoma Metropolitana-Iztapalapa, San Rafael Atlixco 186, Col. Vicentina, Iztapalapa, C. P., 09340 México D. F., Mexico

2. CONACYT—Universidad Autónoma Metropolitana-Iztapalapa, San Rafael Atlixco 186, Col. Vicentina. Iztapalapa, C. P., 09340 México D. F., Mexico

Funder

Consejo Nacional de Ciencia y Tecnolog?a

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.8b02943

Reference134 articles.

1. Recent developments in acute liver failure

2. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation

3. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

4. Acetaminophen and NAPQI are toxic to auditory cells via oxidative and endoplasmic reticulum stress-dependent pathways

5. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential role of angiotensin converting enzyme/neprilysin pathway and protective effects of omapatrilat for paracetamol‑induced acute liver injury;Experimental and Therapeutic Medicine;2022-12-12

2. ESTUDO TEÓRICO E EXPERIMENTAL DE ESTRUTURA E REATIVIDADE RELACIONADO AO METABOLISMO E TOXICIDADE DO PARACETAMOL;Quimica Nova;2022

3. Facile construction of peptidomimetics by sequential C–S/C–N bond activation of Ugi-adducts;Organic Chemistry Frontiers;2021

4. Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction;Protein & Cell;2020-11-18

5. Medicinal Thiols: Current Status and New Perspectives;Mini-Reviews in Medicinal Chemistry;2020-05-11